Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab

Gulleroglu K., Fidan K., Hancer V. S., Bayrakci U., Baskin E., Soylemezoglu O.

PEDIATRIC NEPHROLOGY, cilt.28, sa.5, ss.827-830, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 5
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00467-013-2416-9
  • Dergi Adı: PEDIATRIC NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.827-830
  • Gazi Üniversitesi Adresli: Evet

Özet

Atypical hemolytic uremic syndrome (aHUS) is associated with defective regulation of the complement pathway. Neurological involvement is the most common extrarenal complication and represents a major cause of mortality and morbidity.